3 unchanged sentences
(c) Insider Trading Arrangements and Policies.
−Removed: During the three months ended September 30, 2024, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the three months ended March 31, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.
Number Description
2 unchanged sentences
001-39620) filed on October 20, 2020).
+Added: Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-39620) filed with the Securities and Exchange Commission on December 1, 2023)
Amended and Restated Bylaws of Praxis Precision Medicines, Inc.
5 unchanged sentences
001-39620) filed on March 29, 2024
−Removed: Praxis Precision Medicines, Inc.
−Removed: 2020 Stock Option and Incentive Plan, as amended and restated (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-39620) filed on June 6, 2024)
−Removed: Employment Agreement Amendment Letter, dated October 11, 2024, by and between Marcio Souza and Praxis Precision Medicines, Inc.
−Removed: (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-39620) filed on October 15, 2024)
−Removed: Employment Agreement Amendment Letter, dated October 11, 2024, by and between Timothy Kelly and Praxis Precision Medicines, Inc.
−Removed: (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-39620) filed on October 15, 2024)
−Removed: Employment Agreement Amendment Letter, dated October 11, 2024, by and between Alex Nemiroff and Praxis Precision Medicines, Inc.
−Removed: (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-39620) filed on October 15, 2024)
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
14 unchanged sentences
PRAXIS PRECISION MEDICINES, INC.
−Removed: November 6, 2024 By:
+Added: May 2, 2025 By:
/s/ Marcio Souza
Chief Executive Officer and Director (Principal Executive Officer)
−Removed: November 6, 2024 By:
+Added: May 2, 2025 By:
/s/ Timothy Kelly
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.